Proniras' Partnership

Proniras raised a round of funding on April 27, 2018. Investors include U.S. Department of Health and Human Services.

Proniras Corporation is a Seattle-based biopharmaceutical company focused on developing tezampanel as a medical countermeasure for nerve agent-induced seizures.…

Articles about Proniras' Partnership: